- Home
- TCBS vs RPHM Comparison
TCBS vs RPHM Comparison
Compare TCBS & RPHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- RPHM
- Stock Information
- Founded
- TCBS 1934
- RPHM 2014
- Country
- TCBS United States
- RPHM United States
- Employees
- TCBS N/A
- RPHM N/A
- Industry
- TCBS Banks
- RPHM Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- RPHM Health Care
- Exchange
- TCBS Nasdaq
- RPHM Nasdaq
- Market Cap
- TCBS 46.6M
- RPHM 47.5M
- IPO Year
- TCBS N/A
- RPHM 2021
- Fundamental
- Price
- TCBS $14.88
- RPHM $1.82
- Analyst Decision
- TCBS
- RPHM Hold
- Analyst Count
- TCBS 0
- RPHM 6
- Target Price
- TCBS N/A
- RPHM $2.26
- AVG Volume (30 Days)
- TCBS 1.8K
- RPHM 324.3K
- Earning Date
- TCBS 11-20-2024
- RPHM 11-11-2024
- Dividend Yield
- TCBS 1.08%
- RPHM N/A
- EPS Growth
- TCBS N/A
- RPHM N/A
- EPS
- TCBS N/A
- RPHM N/A
- Revenue
- TCBS $9,785,000.00
- RPHM N/A
- Revenue This Year
- TCBS N/A
- RPHM N/A
- Revenue Next Year
- TCBS N/A
- RPHM N/A
- P/E Ratio
- TCBS N/A
- RPHM N/A
- Revenue Growth
- TCBS N/A
- RPHM N/A
- 52 Week Low
- TCBS $11.78
- RPHM $0.98
- 52 Week High
- TCBS $15.24
- RPHM $9.21
- Technical
- Relative Strength Index (RSI)
- TCBS 64.54
- RPHM 69.89
- Support Level
- TCBS $14.75
- RPHM $1.61
- Resistance Level
- TCBS $14.80
- RPHM $1.75
- Average True Range (ATR)
- TCBS 0.10
- RPHM 0.13
- MACD
- TCBS -0.01
- RPHM 0.04
- Stochastic Oscillator
- TCBS 80.74
- RPHM 87.30
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About RPHM Reneo Pharmaceuticals Inc.
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.